## Abstract Prior to the development of intensive treatments for patients with advanced stage B‐cell non‐Hodgkin's lymphoma (B‐NHL), the prognosis for such patients was dismal. A minority of patients attained long‐term, disease‐free survival. Since 1981, we have treated 28 children with advanced st
Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adults
✍ Scribed by Dr. Vicki A. Morrison; Dr. Glauco Frizzera; Diane C. Arthur; Dr. Kathleen M. Ogle; Dr. David D. Hurd; Dr. Clara D. Bloomfield; Bruce A. Peterson
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 887 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Prognostic factors for long‐term survival of 312 patients with diffuse large cell or immunoblastic non‐Hodgkin's lymphoma are presented based on analysis of the multi‐institution clinicopathologic study sponsored by the National Cancer Institute. At the time of analysis, 75% of the pati
## Background: The pediatric oncology group (pog) conducted a two-arm, randomized study for the treatment of children and adolescents with stage iii small, non-cleaved cell lymphoma (snccl). regimen a, based on the group's previous best treatment for this group of patients, included cyclophosphamid
## Abstract Comparison of the efficacy of different enrichment methods for detection of circulating tumor cells (CTCs) before radical surgery is lacking in non‐small‐cell lung carcinoma (NSCLC) patients. Detection and enumeration of CTCs in 210 consecutive patients undergoing radical surgery for NS